Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 188-206 , January 2008

Peripheral Dual-Energy X-ray Absorptiometry in the Management of Osteoporosis: The 2007 ISCD Official Positions

  • Didier B. Hans

      Affiliations

    • Geneva University Hospital, Geneva, Switzerland
    • Task Force Liaison.
    • Corresponding Author InformationAddress correspondence to: Didier B. Hans, Lausanne University Hospital, Center for Bone Diseases – DAL 1011 Lausanne, Switzerland.
    • ,
  • John A. Shepherd

      Affiliations

    • University of California at San Francisco, San Francisco, CA, USA
    • Task Force Member.
    • ,
  • Elliott N. Schwartz

      Affiliations

    • Northern California Institute for Bone Health, Oakland, CA, USA
    • Task Force Chair.
    • ,
  • David M. Reid

      Affiliations

    • University of Aberdeen, Aberdeen, UK
    • Task Force Chair.
    • ,
  • Glen M. Blake

      Affiliations

    • Guy's Hospital, London, UK
    • Task Force Member.
    • ,
  • John N. Fordham

      Affiliations

    • The James Cook University Hospital, Middleborough, UK
    • Task Force Member.
    • ,
  • Thomas Fuerst

      Affiliations

    • Synarc, Inc., San Francisco, CA, USA
    • Task Force Member.
    • ,
  • Peyman Hadji

      Affiliations

    • Phillipps-Universitat Marburg, Marburg, Germany
    • Task Force Member.
    • ,
  • Akira Itabashi

      Affiliations

    • Saitama Medical School, Moroyama, Saitama, Japan
    • Task Force Member.
    • ,
  • Marc-Antoine Krieg

      Affiliations

    • University Hospital, Lausanne, Switzerland
    • Task Force Member.
    • ,
  • E. Michael Lewiecki

      Affiliations

    • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA
    • Task Force Liaison.

Received 5 December 2007 ,Accepted 5 December 2007.

References 

  1. Cameron JR, Sorenson J. Measurement of Bone Mineral in Vivo: an Improved Method. Science. 1963;142:230–232
  2. Hamdy RC, Petak SM, Lenchik L. Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis?. J Clin Densitom. 2002;5 Suppl:S11–S18
  3. Miller PD, Njeh CF, Jankowski LG, et al. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis?. J Clin Densitom. 2002;5 Suppl:S39–S45
  4. Binkley N, Bilezikian JP, Kendler DL, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006;9(1):4–14
  5. Shepherd JA, Cheng XG, Lu Y, et al. Universal standardization of forearm bone densitometry. J Bone Miner Res. 2002;17(4):734–745
  6. Grigorian M, Shepherd JA, Cheng XG, et al. Does osteoporosis classification using heel BMD agree across manufacturers?. Osteoporos Int. 2002;13(8):613–617
  7. Bouyoucef SE, Cullum ID, Ell PJ. Cross-calibration of a fan-beam X-ray densitometer with a pencil-beam system. Br J Radiol. 1996;69(822):522–531
  8. Hagiwara S, Engelke K, Yang SO, et al. Dual x-ray absorptiometry forearm software: accuracy and intermachine relationship. J Bone Miner Res. 1994;9(9):1425–1427
  9. Faulkner KG, McClung MR, Schmeer MS, et al. Densitometry of the radius using single and dual energy absorptiometry. Calcif Tissue Int. 1994;54(3):208–211
  10. Nilas L, Norgaard H, Podenphant J, et al. Bone composition in the distal forearm. Scand J Clin Lab Invest. 1987;47(1):41–46
  11. Prevrhal S, Lu Y, Genant HK, et al. Towards standardization of dual X-ray absorptiometry (DXA) at the forearm: a common region of interest (ROI) improves the comparability among DXA devices. Calcif Tissue Int. 2005;76(5):348–354
  12. Meszaros S, Berko P, Genti G, et al. Comparative evaluation of local and international reference databases for forearm densitometry: different impacts on diagnostic decisions. J Clin Densitom. 2006;9(4):445–453
  13. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–1259
  14. Seeley DG, Browner WS, Nevitt MC, et al. Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1991;115(11):837–842
  15. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18(11):1947–1954
  16. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993;341(8837):72–75
  17. Sornay-Rendu E, Munoz F, Duboeuf F, et al. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res. 2005;20(11):1929–1935
  18. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002;17(12):2222–2230
  19. Siris ES, Brenneman SK, Barrett-Connor E, et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2006;17(4):565–574
  20. Holmberg A, Johnell O, Akesson K, et al. Forearm bone mineral density in 1294 middle-aged women: a strong predictor of fragility fractures. J Clin Densitom. 2004;7(4):419–423
  21. Riis BJ, Hansen MA, Jensen AM, et al. Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone. 1996;19(1):9–12
  22. Gardsell P, Johnell O, Nilsson BE. The predictive value of bone loss for fragility fractures in women: a longitudinal study over 15 years. Calcif Tissue Int. 1991;49(2):90–94
  23. Ross PD, Kress BC, Parson RE, et al. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int. 2000;11(1):76–82
  24. Huang C, Ross PD, Wasnich RD. Short-term and long-term fracture prediction by bone mass measurements: a prospective study. J Bone Miner Res. 1998;13(1):107–113
  25. Barr RJ, Adebajo A, Fraser WD, et al. Can peripheral DXA measurements be used to predict fractures in elderly women living in the community?. Osteoporos Int. 2005;16(10):1177–1183
  26. Blake GM, Chinn DJ, Steel SA, et al. A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int. 2005;16(12):2149–2156
  27. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929–1936
  28. Blake GM, Fogelman I. Peripheral or central densitometry: does it matter which technique we use?. J Clin Densitom. 2001;4(2):83–96
  29. Gardsell P, Johnell O, Nilsson BE. The predictive value of forearm bone mineral content measurements in men. Bone. 1990;11(4):229–232
  30. Hongsdusit N, von Muhlen D, Barrett-Connor E. A comparison between peripheral BMD and central BMD measurements in the prediction of spine fractures in men. Osteoporos Int. 2006;17(6):872–877
  31. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–194
  32. Clowes JA, Eastell R, Peel NF. The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study. Osteoporos Int. 2005;16(12):1794–1802
  33. Black DM, Cummings SR, Genant HK, et al. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res. 1992;7(6):633–638
  34. Cummings SR, Black DM, Nevitt MC, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990;263(5):665–668
  35. Nevitt MC, Johnell O, Black DM, et al. Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int. 1994;4(6):325–331
  36. Saleh MM, Jorgensen HL, Lauritzen JB. Odds ratios for hip- and lower forearm fracture using peripheral bone densitometry; a case-control study of postmenopausal women. Clin Physiol Funct Imaging. 2002;22(1):58–63
  37. Broe KE, Hannan MT, Kiely DK, et al. Predicting fractures using bone mineral density: a prospective study of long-term care residents. Osteoporos Int. 2000;11(9):765–771
  38. Hui SL, Slemenda CW, Johnston CC. Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989;111(5):355–361
  39. Overgaard K, Hansen MA, Riis BJ, et al. Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women. Calcif Tissue Int. 1992;50(1):30–35
  40. Gardsell P, Johnell O, Nilsson BE, et al. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int. 1993;52(5):348–353
  41. Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–1141
  42. Hans D, Downs RW, Duboeuf F, et al. Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9(1):15–21
  43. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom. 1999;2(3):343–350
  44. Lu Y, Genant HK, Shepherd J, et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res. 2001;16(5):901–910
  45. Svendsen OL, Hassager C, Skodt V, et al. Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study. J Bone Miner Res. 1995;10(6):868–873
  46. Blake GM, Knapp KM, Fogelman I. Absolute fracture risk varies with bone densitometry technique used. A theoretical and in vivo study of fracture cases. J Clin Densitom. 2002;5(2):109–116
  47. McCauley E, Mackie A, Elliott D, et al. Heel bone densitometry: device specific thresholds for the assessment of osteoporosis. Br J Radiol. 2006;79(942):464–467
  48. Clowes JA, Peel NF, Eastell R. Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice. Osteoporos Int. 2006;17(9):1293–1302
  49. Boyanov M. Forearm single X-ray absorptiometry in the identification of postmenopausal women with osteoporosis at the hip and spine: a correlation study. J Clin Densitom. 2005;8(4):423–429
  50. Damilakis J, Papadokostakis G, Perisinakis K, et al. Can radial bone mineral density and quantitative ultrasound measurements reduce the number of women who need axial density skeletal assessment?. Osteoporos Int. 2003;14(8):688–693
  51. Fordham JN, Chinn DJ, Kumar N. Identification of women with reduced bone density at the lumbar spine and femoral neck using BMD at the os calcis. Osteoporos Int. 2000;11(9):797–802
  52. Goemaere S, Zmierczak H, Van Pottelbergh I, et al. Ability of peripheral bone assessments to predict areal bone mineral density at hip in community-dwelling elderly men. J Clin Densitom. 2002;5(3):219–228
  53. Mulder JE, Michaeli D, Flaster ER, et al. Comparison of bone mineral density of the phalanges, lumbar spine, hip, and forearm for the assessment of osteoporosis in postmenopausal women. J Clin Densitom. 2000;3(4):373–381
  54. Pearson D, Masud T, Sahota O, et al. A comparison of calcaneal dual-energy X-ray absorptiometry and calcaneal ultrasound for predicting the diagnosis of osteoporosis from hip and spine bone densitometry. J Clin Densitom. 2003;6(4):345–352
  55. Thorpe JA, Steel SA. The DXL Calscan heel densitometer: evaluation and diagnostic thresholds. Br J Radiol. 2006;79(940):336–341
  56. Pouilles JM, Tremollieres FA, Martinez S, et al. Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause. Osteoporos Int. 2001;12(1):71–76
  57. Picard D, Brown JP, Rosenthall L, et al. Ability of peripheral DXA measurement to diagnose osteoporosis as assessed by central DXA measurement. J Clin Densitom. 2004;7(1):111–118
  58. Langton CM, Langton DK. Comparison of bone mineral density and quantitative ultrasound of the calcaneus: site-matched correlation and discrimination of axial BMD status. Br J Radiol. 2000;73(865):31–35
  59. Patel R, Blake GM, Fogelman I. An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry. Osteoporos Int. 2004;15(6):497–504
  60. Durosier C, Hans D, Krieg MA, et al. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture. Osteoporos Int. 2007;18(12):1651–1659
  61. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–1046
  62. Durosier C, Hans D, Krieg MA, et al. Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J Clin Densitom. 2006;9(4):475–495
  63. Martin JC, Munro R, Campbell MK, et al. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol. 1997;36(1):43–49
  64. Chen YT, Miller PD, Barrett-Connor E, et al. An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int. 2007;18(9):1287–1296
  65. Abbott TA, Mucha L, Manfredonia D, et al. Efficient patient identification strategies for women with osteoporosis. J Clin Densitom. 1999;2(3):223–230
  66. Harrison EJ, Adams JE. Application of a triage approach to peripheral bone densitometry reduces the requirement for central DXA but is not cost effective. Calcif Tissue Int. 2006;79(4):199–206
  67. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16(6):581–589
  68. De Laet C, Oden A, Johansson H, et al. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int. 2005;16(3):313–318
  69. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20(7):1185–1194
  70. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847
  71. Hans D, Schott AM, Durosier C, et al. 2006 Ten-year probability of osteoporotic hip fracture in 12958 elderly women combining clinical factors and heel bone ultrasound: The combined “SEMOF+EPIDOS” prospective cohort. ASBMR 28th Annual meeting, vol. 21. J Bone Miner Res Philadelphia, USA, 2006, pp 1297.
  72. Ito M, Nishida A, Kono J, et al. Which bone densitometry and which skeletal site are clinically useful for monitoring bone mass?. Osteoporos Int. 2003;14(12):959–964
  73. Heilmann P, Wuster C, Prolingheuer C, et al. Measurement of forearm bone mineral density: comparison of precision of five different instruments. Calcif Tissue Int. 1998;62(5):383–387
  74. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535–1541
  75. McClung MR, Wasnich RD, Hosking DJ, et al. Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study. J Clin Endocrinol Metab. 2004;89(10):4879–4885
  76. Bouxsein ML, Parker RA, Greenspan SL. Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women. Osteoporos Int. 1999;10(6):505–509
  77. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–1441
  78. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003;349(13):1207–1215
  79. Black DM, Bilezikian JP, Ensrud KE, et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med. 2005;353(6):555–565
  80. Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, et al. A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants. Humanit Rep. 2006;21(2):466–470
  81. Bahamondes L, Perrotti M, Castro S, et al. Forearm bone density in users of Depo-Provera as a contraceptive method. Fertil Steril. 1999;71(5):849–852
  82. Petitti DB, Piaggio G, Mehta S, et al. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol. 2000;95(5):736–744
  83. Gutteridge DH, Stewart GO, Prince RL, et al. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Osteoporos Int. 2002;13(2):158–170
  84. Ravn P, Alexandersen P, Mollgaard A. Bone densitometry: a new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment. Osteoporos Int. 1999;9(4):277–283
  85. Rosvold Berntsen GK, Fonnebo V, Tollan A, et al. The Tromso study: determinants of precision in bone densitometry. J Clin Epidemiol. 2000;53(11):1104–1112
  86. Emaus N, Berntsen GK, Joakimsen R, et al. Longitudinal changes in forearm bone mineral density in women and men aged 45-84 years: the Tromso Study, a population-based study. Am J Epidemiol. 2006;163(5):441–449
  87. Emaus N, Berntsen GK, Joakimsen RM, et al. Longitudinal changes in forearm bone mineral density in women and men aged 25-44 years: the Tromso study: a population-based study. Am J Epidemiol. 2005;162(7):633–643
  88. Elgan C, Dykes AK, Samsioe G. Bone mineral density changes in young women: a two year study. Gynecol Endocrinol. 2004;19(4):169–177
  89. The writing Group for the ISCD Position Development Conference . Indications and reporting for dual-energy x-ray absorptiometry. J Clin Densitom. 2004;7(1):37–44
  90. Adebajo A, Campbell L, Hitchcock J. Evaluating a nurse-led DXA scanning service. Nurs Stand. 2006;20(51):35–39
  91. Berntsen GK, Tollan A, Magnus JH, et al. The Tromso Study: artifacts in forearm bone densitometry–prevalence and effect. Osteoporos Int. 1999;10(5):425–432

PII: S1094-6950(07)00260-0

doi: 10.1016/j.jocd.2007.12.012

Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 188-206 , January 2008

Article Tools

* Image Usage & Resolution